The stock market is tumbling. Wall Street is rife with talk of a possible recession. Even the chairman of the Federal Reserve can’t say for sure what’s coming down the pike. High levels of ...

Embezzlement and polarizing legal decisions aren’t new, of course. But the crisis of Western democracy, most fundamentally, is about voters’ perception that decisions are taken out of their hands.

For someone who began her television journey with a checklist, Maahi Gouthami is in a happy place. The past few months have been both hectic and fulfilling, as she was able to tick off the dates ...

A common neurotoxin produced by algae blooms is making California sea lions more aggressive. Here’s why it has the power to change behavior—and the danger it poses. Rescuers capture a sick sea ...

Even Mag 7 stocks are not safe from tariffs. In Apple’s case, they are probably the most exposed to retaliatory tariffs against China. While Monday’s market bounce provided a bit of respite of ...

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters. America is witnessing an unprecedented series of attacks on higher education that ...

"If we want to change workplace culture, engagement has to start at the top." Employees aren’t asking for less work—they’re asking for leadership that values them. Without that, disengagement is ...

Exposure to fine particulate air pollution (PM 2.5) from wildfire smoke is linked to increased emergency department (ED) visits for mental health conditions, according to a recent study. The ...

This post originally appeared in the Business Insider Today newsletter. You can sign up for Business Insider's daily newsletter here. Good morning. Boomers told BI they are preparing for the worst ...

FOR WHOM THE TOLLS BILL — Congestion pricing is here until at least early fall, legal filing suggests, by POLITICO’s Ry Rivard: New York’s congestion pricing tolls aren’t going anywhere ...

Billionaire Bridgewater Associates founder Ray Dalio warned that tariffs aren’t the biggest problem investors face right now. While he acknowledges the damage tariffs are doing to the stock ...

That's why Tilray is still not worth investing in today, even for less than $1 per share. Things aren't going particularly well for Novavax, a vaccine maker that made some noise in the COVID-19 space.